Keyphrases
Peru
100%
Antimicrobial Resistance
100%
Bloodstream Infection
100%
Economic Cost
100%
Late-onset Sepsis
50%
Microorganisms
33%
Bacteremia
33%
Multidrug Resistance
33%
Resistant Strains
33%
Cost of Illness
33%
Lima
16%
Low-middle Income Countries
16%
Public Health
16%
Direct Costs
16%
Health Authorities
16%
Antimicrobial Susceptibility
16%
Acinetobacter
16%
Global Economy
16%
Invoice
16%
Cost Increase
16%
Strengthening Measure
16%
Pseudomonas
16%
January 2017
16%
Micro-costing
16%
Resistance of Microorganisms
16%
Strain Identification
16%
Medicine and Dentistry
Health Care Cost
100%
Neonatal Infant
100%
Antibiotic Resistance
100%
Bloodstream Infection
100%
Sepsis
25%
Multidrug Resistance
16%
Cross Sectional Study
8%
Public Health
8%
Antibiogram
8%
Acinetobacter
8%
Strain Identification
8%
Pseudomonas
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
100%
Antibiotic Resistance
100%
Sepsis
50%
Microorganism
50%
Multidrug Resistance
33%
Antiinfective Agent
16%
Acinetobacter
16%
Pseudomonas
16%
Cross-Sectional Study
16%
Immunology and Microbiology
Infection
100%
Antibiotic Resistance
100%
Microorganism
50%
Multidrug Resistance
33%
Antibiotic Sensitivity
16%
Acinetobacter
16%
Pseudomonas
16%
Strain Identification
16%
Nursing and Health Professions
Bloodstream Infection
100%
Antibiotic Resistance
100%
Sepsis
50%
Antiinfective Agent
16%
Strain Identification
16%
Cross-Sectional Study
16%
Public Health
16%